Page last updated: 2024-11-05

dibromoacetic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Dibromoacetic acid is a colorless to pale yellow liquid with a pungent odor. It is a strong acid and is corrosive to skin and eyes. It is soluble in water, ethanol, and ether. Dibromoacetic acid is used as a reagent in organic synthesis and as a catalyst in some industrial processes. It is also used in the production of pharmaceuticals and pesticides. Dibromoacetic acid is a potent inhibitor of the enzyme carbonic anhydrase. It is also known to have antibacterial and antifungal properties. Dibromoacetic acid is a halogenated carboxylic acid. It is a potent inhibitor of carbonic anhydrase, an enzyme that plays a role in the regulation of pH and carbon dioxide levels in the body. Dibromoacetic acid is a strong acid and is corrosive to skin and eyes. It is a volatile compound and should be handled with caution.'

dibromoacetic acid : A monocarboxylic acid that is acetic acid in which two of the methyl hydrogens are replaced by bromo groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12433
CHEMBL ID449362
CHEBI ID90124
SCHEMBL ID137199
MeSH IDM0234634

Synonyms (42)

Synonym
hsdb 7622
acetic acid, 2,2-dibromo-
7fuw62yy5l ,
unii-7fuw62yy5l
dibromoacetic acid
acetic acid, dibromo-
inchi=1/c2h2br2o2/c3-1(4)2(5)6/h1h,(h,5,6
631-64-1
NCGC00090913-01
einecs 211-165-5
ccris 7636
dibromoacetate
dibromoacetic acid, analytical standard
dibromoacetic acid, 97%
2,2-dibromoacetic acid
MLS001065597
smr000568475
chebi:90124 ,
CHEMBL449362
AKOS000119767
NCGC00090913-02
LMFA01090076
dbaa
2,2-dibromoethanoic acid
C20123
cas-631-64-1
dtxcid203815
tox21_303291
dtxsid1023815 ,
NCGC00257152-01
tox21_202297
NCGC00259846-01
10024-50-7
FT-0632681
SCHEMBL137199
dibromoacetic acid [hsdb]
dibromoacetic acid [iarc]
dibromoethanoic acid
dibromoacetic acid 1000 microg/ml in methyl-tert-butyl ether
dibromoaceticacid
Q18533477
s29 - haloacetic acids

Research Excerpts

Overview

Dibromoacetic acid (DBA) is a disinfection by-product commonly found in drinking water as a result of chlorination/ ozonation processes. It could cause many adverse effects in test animals.

ExcerptReferenceRelevance
"Dibromoacetic acid (DBA) is a by-product of disinfection in drinking water, which could cause many adverse effects in test animals. "( Dibromoacetic acid exposure is associated with abnormal melatonin rhythm in rats via inhibition of p-CREB1-AANAT signalling pathway.
Cao, F; Gu, W; Guo, R; Han, T; Jiang, W; Jiang, X; Li, Y; Liu, X; Sun, C; Wang, Y; Wu, H; Xu, X; Yan, X, 2021
)
3.51
"Dibromoacetic acid (DBA) is a haloacetic acid that is present in drinking water as a by-product of chlorinated disinfection. "( Subacute oral exposure to dibromoacetic acid induced immunotoxicity and apoptosis in the spleen and thymus of the mice.
Dong, Y; Gao, S; Li, B; Wang, Y; Zhang, P, 2008
)
2.09
"Dibromoacetic acid (DBA) is a disinfection by-product commonly found in drinking water as a result of chlorination/ ozonation processes. "( Immunotoxicity of dibromoacetic acid administered via drinking water to female B₆C₃F₁ mice.
Auttachoat, W; Germolec, DR; Guo, TL; Luebke, RW; Sheth, CM; Smith, MJ; White, KL,
)
1.91
"Dibromoacetic acid (DBA) is a drinking water disinfection by-product. "( Effect of dibromoacetic acid on DNA methylation, glycogen accumulation, and peroxisome proliferation in mouse and rat liver.
Kramer, PM; Li, L; Pereira, MA; Tao, L; Wang, W, 2004
)
2.17
"Dibromoacetic acid (DBA) is a water disinfection byproduct formed by the reaction of chlorine oxidizing compounds with natural organic matter in water containing bromide. "( Toxicity and carcinogenicity of the water disinfection byproduct, dibromoacetic acid, in rats and mice.
Foster, PM; Kissling, GE; Melnick, RL; Nyska, A; Roycroft, JH, 2007
)
2.02
"Dibromoacetic acid is a water disinfection by-product. "( Toxicology and carcinogenesis studies of dibromoacetic acid (Cas No. 631-64-1) in F344/N rats and B6C3F1 mice (drinking water studies).
, 2007
)
2.05
"Dibromoacetic acid (DBA) is a by-product of drinking water disinfection that alters spermatogenesis in adult male rats. "( Dibromoacetic acid, a prevalent by-product of drinking water disinfection, compromises the synthesis of specific seminiferous tubule proteins following both in vivo and in vitro exposures.
Holmes, M; Klinefelter, GR; Mole, ML; Murr, AS; Roberts, NL; Suarez, JD,
)
3.02

Toxicity

ExcerptReferenceRelevance
"An evaluation of potential adverse human health effects of disinfection byproducts requires study of both cancer and noncancer endpoints; however, no studies have evaluated the neurotoxic potential of a common haloacetic acid, dibromoacetic acid (DBA)."( Neurotoxicity produced by dibromoacetic acid in drinking water of rats.
Butt, MT; Jortner, BS; Levine, AB; McDaniel, KL; Moser, VC; Phillips, PM; Sills, RC, 2004
)
0.81
" We have previously shown that the haloacetic acids (HAs), dichloro (DCA), dibromo (DBA) and bromochloro (BCA) acetic acid are developmentally toxic in mouse whole embryo culture."( Developmental toxicity of mixtures: the water disinfection by-products dichloro-, dibromo- and bromochloro acetic acid in rat embryo culture.
Andrews, JE; Hunter, ES; Klinefelter, GR; Mole, LM; Nichols, HP; Schmid, JE, 2004
)
0.32
" Toxic effects of DBA in the prechronic studies were detected in the liver (hepatocellular cytoplasmic vacuolization in rats and mice) and testes (delayed spermiation and atypical residual bodies in male rats and mice, and atrophy of the germinal epithelium in rats)."( Toxicity and carcinogenicity of the water disinfection byproduct, dibromoacetic acid, in rats and mice.
Foster, PM; Kissling, GE; Melnick, RL; Nyska, A; Roycroft, JH, 2007
)
0.58
" To evaluate its potential adverse health effects, the immunotoxicological effects of DBA on the thymus and spleen of BALB/c mice were investigated."( Subacute oral exposure to dibromoacetic acid induced immunotoxicity and apoptosis in the spleen and thymus of the mice.
Dong, Y; Gao, S; Li, B; Wang, Y; Zhang, P, 2008
)
0.65
" The role of gastrointestinal degradation in the toxic effects of DBPs still needs further investigation."( Gastrointestinal Degradation and Toxicity of Disinfection Byproducts in Drinking Water Using
Hu, B; Li, D; Wang, P; Yin, J; Zheng, T, 2023
)
0.91

Bioavailability

ExcerptReferenceRelevance
" Exposure to HAAs is influenced by consumption patterns and diet of individuals thus their bioavailability is an important parameter to the overall toxicity."( In vitro bioacessibility and transport across Caco-2 monolayers of haloacetic acids in drinking water.
Faria, MA; Ferreira, IMPLVO; Mansilha, C; Melo, A; Pinto, E, 2016
)
0.43

Dosage Studied

ExcerptRelevanceReference
" In rats dosed with DBAA, serum testosterone fell to 17% of control 2 days after a single dose of 1250 mg/kg but returned to control levels by Day 14."( Acute spermatogenic effects of bromoacetic acids.
Dyer, CJ; Klinefelter, GR; Linder, RE; Strader, LF; Suarez, JD, 1994
)
0.29
" In rats dosed with 270 mg/kg/day, there were marked effects on epididymal sperm motility and morphology including the flagellar fusion of 2 or more sperm."( Spermatotoxicity of dibromoacetic acid in rats after 14 daily exposures.
Dyer, CJ; Klinefelter, GR; Linder, RE; Roberts, NL; Strader, LF; Suarez, JD,
)
0.45
" DBAA compromised male fertility during the second treatment week in naturally bred rats dosed with 250 mg/kg."( Dibromoacetic acid affects reproductive competence and sperm quality in the male rat.
Klinefelter, GR; Linder, RE; Narotsky, MG; Perreault, SD; Roberts, NL; Strader, LF; Suarez, JD, 1995
)
1.73
" On treatment day 2 abnormal retention of Step 19 spermatids was observed in animals given the highest dosage of 250 mg/kg."( Histopathologic changes in the testes of rats exposed to dibromoacetic acid.
Klinefelter, GR; Linder, RE; Roberts, NL; Strader, LF; Suarez, JD; Veeramachaneni, DN,
)
0.38
" Delayed spermiation and formation of atypical residual bodies also were observed on days 2, 5, 9, and 14 in rats dosed daily with 1440, 480, 160, and 54 mg/kg."( Spermatotoxicity of dichloroacetic acid.
Klinefelter, GR; Linder, RE; Roberts, NL; Strader, LF; Suarez, JD,
)
0.13
" Regularly cycling animals were dosed with DBA (0 to 270 mg/kg/day) for 14 days and estrous cyclicity was monitored during treatment and for an additional 2-week posttreatment interval."( Influence of the drinking water disinfection by-product dibromoacetic acid on rat estrous cyclicity and ovarian follicular steroid release in vitro.
Balchak, SK; Goldman, JM; Hedge, JM; Mole, ML; Murr, AS,
)
0.38
" Four groups of 6- or 8-week old male SD rats were given DBAA at a daily dosage of 0, 5, 50 or 250 mg/kg."( Collaborative work to evaluate toxicity on male reproductive organs by repeated dose studies in rats 25). Effects of 2- and 4- week repeated-dosing of dibromoacetic acid.
Murakami, T; Mutai, M; Ooyama, N; Sano, F; Sugimoto, J; Tsuchiya, T, 2000
)
0.51
" The present experiments focused on establishing a dose-response for such an effect and identifying the point(s)of impact of this compound along the steroidogenic pathway that underlie this suppression."( Alterations in ovarian follicular progesterone secretion by elevated exposures to the drinking water disinfection by-product dibromoacetic acid: examination of the potential site(s) of impact along the steroidogenic pathway.
Goldman, JM; Murr, AS, 2002
)
0.52
" Testing with a functional observational battery and motor activity took place before dosing and at 1, 2, 4, and 6 months."( Neurotoxicity produced by dibromoacetic acid in drinking water of rats.
Butt, MT; Jortner, BS; Levine, AB; McDaniel, KL; Moser, VC; Phillips, PM; Sills, RC, 2004
)
0.62
" The remaining pups (15-17 of each gender/dose group) continued to be dosed similarly through adulthood."( Sub-chronic exposure to dibromoacetic acid, a water disinfection by-product, does not affect gametogenic potential in mice.
Legare, ME; Sawyer, HR; Veeramachaneni, DN; Weber, NM, 2006
)
0.64
" Sprague-Dawley rats were gavaged for 14 days with DBA (0-150mg/kg) and ovariectomized on dosing day 11, and at the same time implanted with an estradiol capsule to generate daily LH surges."( Moderating influence of the drinking water disinfection by-product dibromoacetic acid on a dithiocarbamate-induced suppression of the luteinizing hormone surge in female rats.
Buckalew, AR; Cooper, RL; Ferrell, JM; Goldman, JM; Murr, AS, 2007
)
0.58
" Testes were collected from male Sprague-Dawley rats dosed orally for 1 and 4 days with DBAA at 250 mg/kg/day."( Role of cytochrome P450c17α in dibromoacetic acid-induced testicular toxicity in rats.
Blomme, EA; Carr, TL; Ciurlionis, R; Liguori, MJ; Milicic, I; Strakhova, MI; Warder, SE; Whitney, K, 2011
)
0.66
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
marine metaboliteAny metabolite produced during a metabolic reaction in marine macro- and microorganisms.
apoptosis inducerAny substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
geroprotectorAny compound that supports healthy aging, slows the biological aging process, or extends lifespan.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
monocarboxylic acidAn oxoacid containing a single carboxy group.
2-bromocarboxylic acidAny carboxylic acid in which the carbon bearing the carboxy group is substituted by a bromine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (12)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency11.22020.003245.467312,589.2998AID2517
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency35.48130.125919.1169125.8920AID2549
interleukin 8Homo sapiens (human)Potency74.97800.047349.480674.9780AID651758
RAR-related orphan receptor gammaMus musculus (house mouse)Potency26.45770.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency6.85900.000714.592883.7951AID1259369
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency44.66840.011212.4002100.0000AID1030
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency0.61810.001022.650876.6163AID1224893
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency16.90360.000214.376460.0339AID588532; AID588533
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency61.13060.003041.611522,387.1992AID1159552; AID1159555
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency28.18380.023723.228263.5986AID588543
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency39.81070.010039.53711,122.0200AID1479
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency5.02890.000627.21521,122.0200AID651741; AID720636; AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID384212Mutagenic activity in Salmonella Typhimurium TA100 assessed as logarithm of his+ revertant number increasing activity by amens test2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Halogenated derivatives QSAR model using spectral moments to predict haloacetic acids (HAA) mutagenicity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (56)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.79)18.7374
1990's7 (12.50)18.2507
2000's26 (46.43)29.6817
2010's19 (33.93)24.3611
2020's3 (5.36)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.57 (24.57)
Research Supply Index4.26 (2.92)
Research Growth Index5.48 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.43%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other69 (98.57%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]